Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data

BACKGROUND: Immunotherapies have advanced the treatment of metastatic melanoma; however, they are associated with immune-related toxicities. Patients with pre-existing autoimmune comorbidities are commonly excluded from clinical trials investigating immunotherapies in metastatic melanoma. Since info...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Qiufei, Shilkrut, Mark, Zhao, Zhongyun, Li, Minming, Batty, Nicolas, Barber, Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801837/
https://www.ncbi.nlm.nih.gov/pubmed/29409500
http://dx.doi.org/10.1186/s12885-018-4051-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801837/
https://www.ncbi.nlm.nih.gov/pubmed/29409500
http://dx.doi.org/10.1186/s12885-018-4051-0

Ejemplares similares